Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy
01:00pm, Wednesday, 13'th Nov 2024
Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Quest Diagnostics Stock a Smart Addition to Your Portfolio Now?
09:20am, Wednesday, 13'th Nov 2024
DGX exhibits strength in its base business. Increasing utilization of the Advanced Diagnostics offering is another positive.
Quest Diagnostics Declares Quarterly Cash Dividend
05:57pm, Tuesday, 12'th Nov 2024
SECAUCUS, N.J. , Nov. 12, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividen
DGX vs. PNTG: Which Stock Is the Better Value Option?
12:45pm, Monday, 11'th Nov 2024
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Quest Diagnostics (DGX) and The Pennant Group, Inc. (PNTG). But which of these two companies is the bes
Here's Why You Should Retain DGX Stock in Your Portfolio Now
08:56am, Monday, 04'th Nov 2024
Investors feel optimistic about Quest Diagnostics' strength in Advanced Diagnostics. Robust base business volumes are also encouraging.
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?
10:16am, Friday, 25'th Oct 2024
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base
10:10am, Thursday, 24'th Oct 2024
Quest Diagnostics benefits from an aging population, driving increased lab testing volumes, particularly in genetic testing, and offers a 2.0% dividend yield. DGX's M&A strategy, including the LifeLab
Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat
08:36am, Thursday, 24'th Oct 2024
Quest Diagnostics reported strong Q3 earnings, with an 8.5% revenue increase and a 3.6% rise in diluted EPS, beating Street expectations. The company raised its 2024 revenue guidance and expects signi
DGX or PNTG: Which Is the Better Value Stock Right Now?
12:45pm, Wednesday, 23'rd Oct 2024
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Quest Diagnostics (DGX) or The Pennant Group, Inc. (PNTG). But which of these two comp
4 Stocks to Buy in an Evolving Outpatient Home Health Industry
12:05pm, Wednesday, 23'rd Oct 2024
Dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, AMED and ADUS are well-poised
US lab operator Quest Diagnostics to launch bird flu test at end of October
08:08am, Wednesday, 23'rd Oct 2024
Lab operator Quest Diagnostics said on Wednesday it will launch a test for H5N1 bird flu at the end of October after the U.S. Centers for Disease Control and Prevention (CDC) gave it contracts to supp
Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development
07:53am, Wednesday, 23'rd Oct 2024
Quest to develop laboratory tests and support public health reporting and laboratory readiness for CDC's preparedness strategy; Company to introduce clinical testing for avian flu later this month ba
Overlooked Stock: DGX
04:57pm, Tuesday, 22'nd Oct 2024
One of the biggest earnings movers from Tuesday: Quest Diagnostics (DGX). The lab & testing company beat on the top-and-bottom line in its 3Q report, as shares surged to multi-month highs.
Quest Diagnostics (DGX) Q3 2024 Earnings Call Transcript
11:40am, Tuesday, 22'nd Oct 2024
Quest Diagnostics Incorporated (NYSE:DGX ) Q3 2024 Earnings Conference Call October 22, 2023 8:30 AM ET Company Participants Jim Davis - President, Chief Executive Officer Sam Samad - Executive Vice P
Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025
11:08am, Tuesday, 22'nd Oct 2024
Quest Diagnostics Inc DGX posted third-quarter adjusted earnings per share of $2.30, beating the consensus of $2.26.
